Tuned Stem Cell EVs for Chronic Wounds

About ZenBio

ZenBio is a long-established provider of critical biological research tools and contract services, with a core focus on human adipocytes and stem cells for regenerative medicine and cosmetics applications. The company has built a reputation for high-quality, consistent cell-based products and has recently expanded its capabilities into exosome and extracellular vesicle therapeutics, as evidenced by multiple awarded SBIR grants. In August 2024, ZenBio was acquired by BioIVT, a strategic move that integrates it into a larger global research model provider, enhancing its distribution and service reach while continuing its independent research programs.

Therapeutic Areas

Other Chronic Wounds Drugs